TECHNICAL FIELD OF THE INVENTION
The present invention relates to a novel monoclonal antibody reactive with human carcinoma cells. More particularly, the antibody of the invention is a monoclonal antibody that reacts with a glycolipid cell membrane antigen found on the surface of human carcinomas,